Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

FILE PHOTO: Wegovy maker Novo Nordisk said it will cut the price of the weight-loss medication to $199 for one month for new customers.

Hims, Ro and LifeMD will soon start selling Wegovy at a reduced price of $499 per month.

Zepbound outperforms Wegovy in weight loss, with participants losing significantly more weight in the first head-to-head trial of these obesity drugs.

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.

How Was Wegovy Studied for Weight Loss? Several studies were done on the risks and benefits of Wegovy in adults and adolescents ages 12 and older with excess weight.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

Wegovy is a prescription drug used for long-term weight management. Learn about the side effects it can cause and how to manage them.

Ozempic and Wegovy are two prescription drugs that may be used for weight loss in certain people. Find out how these drugs compare.

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday.

The Phase 3 clinical trial found that Wegovy reduced inflammation and scarring in people with metabolic dysfunction-associated steatohepatitis, or MASH.